Novartis hands investors Alcon spin-off and $5bn share buyback
Eyecare business had been problematic since Novartis bought it for $52 billion in 2011
Novartis plans to buy back $5bn in stock over next two years
Pharma firm will expand in faster-growing areas of healthcare
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Six Nations 2025
Get the latest news, analysis and match reports from the M6N and W6N championships
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices